| Identification | Back Directory | [Name]
(S)-Methyl 2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetate | [CAS]
1000414-38-9 | [Synonyms]
(S)-Methyl 6-Hydroxy-2,3-dihydrobenzofuran-3-ylacetate
S)-Methyl 2-(hydroxy-2,3-dihydrobenzofuran-3-yl)acetate
(S)-Methyl 2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetate
(S)-Methyl 6-Hydroxy-2,3-dihydrobenzofuran-3-ylacetate,99%e.e.
methyl 2-[(3S)-6-hydroxy-2,3-dihydro-1-benzofuran-3-yl]acetate
(3S)-2,3-Dihydro-6-hydroxy-3-benzofuranacetic acid methyl ester
(S) 3- Benzofuranacetic acid, 2,3-dihydro-6-hydroxy-, Methyl ester
(S)-(6-Hydroxy-2,3-dihydrobenzofuran-3-yl)acetic Acid Methyl Ester
3-Benzofuranacetic acid, 2,3-dihydro-6-hydroxy-, methyl ester, (3S)- | [Molecular Formula]
C11H12O4 | [MDL Number]
MFCD20488619 | [MOL File]
1000414-38-9.mol | [Molecular Weight]
208.211 |
| Chemical Properties | Back Directory | [Boiling point ]
326.5±42.0 °C(Predicted) | [density ]
1.257±0.06 g/cm3(Predicted) | [storage temp. ]
Sealed in dry,2-8°C | [pka]
9.77±0.40(Predicted) |
| Hazard Information | Back Directory | [Uses]
(S)-(6-Hydroxy-2,3-dihydrobenzofuran-3-yl)acetic Acid Methyl Ester is the (S)-Isomer of (6-Hydroxy-2,3-dihydrobenzofuran-3-yl)acetic Acid Methyl Ester (H947905), an synthetic intermediate of TAK-875 (
T004915), a novel oral medication that has been developed to improve the secretion of insulin in a glucose-dependent manner. |
|
|